Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6FLF3

Entry ID Method Resolution Chain Position Source
AF-Q6FLF3-F1 Predicted AlphaFoldDB

No variants for Q6FLF3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6FLF3

No associated diseases with Q6FLF3

5 regional properties for Q6FLF3

Type Name Position InterPro Accession
conserved_site ATP-dependent RNA helicase DEAD-box, conserved site 262 - 270 IPR000629
domain Helicase, C-terminal 331 - 491 IPR001650
domain DEAD/DEAH box helicase domain 134 - 305 IPR011545
domain Helicase superfamily 1/2, ATP-binding domain 129 - 332 IPR014001
domain RNA helicase, DEAD-box type, Q motif 110 - 138 IPR014014

Functions

Description
EC Number 3.6.4.13 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Cytoplasm
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

5 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
RNA helicase activity Unwinding of an RNA helix, driven by ATP hydrolysis.
snoRNA binding Binding to a small nucleolar RNA.

5 GO annotations of biological process

Name Definition
messenger ribonucleoprotein complex assembly The aggregation, arrangement and bonding together of proteins and messenger RNA (mRNA) molecules to form a messenger ribonucleoprotein (mRNP) complex.
nuclear polyadenylation-dependent mRNA catabolic process The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target mRNA.
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.
rRNA processing Any process involved in the conversion of a primary ribosomal RNA (rRNA) transcript into one or more mature rRNA molecules.
termination of RNA polymerase II transcription A transcription termination process that completes the production of a primary RNA polymerase II transcript.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MGYRDALYNK TNYNSRGGDF RGGRSSDRND YNRDRNQGYS HGGLRGRHDD GPRELIKPDW
70 80 90 100 110 120
ESELPNLPPF EKNFYVEHEV VRNRSDQEVA QFRKESEMTI TGHDIPKPIT TFDEAGFPDY
130 140 150 160 170 180
VLKEVKAEGF DKPTSIQCQG WPMALSGRDM VGIAATGSGK TLSYCLPGIV HINAQPLLSP
190 200 210 220 230 240
GDGPIVLVLA PTRELAVQIQ KECSKFGKSS RIRNTCVYGG VPRGQQIREL IRGAEIVIAT
250 260 270 280 290 300
PGRLIDMLEA GKTNLKRVTY LVLDEADRML DMGFEPQIRK IVDQIRPDRQ TLMWSATWPK
310 320 330 340 350 360
EVQQLARDYL NDPIQVQIGS LELAASHNIT QLVEVVSEFE KRDRLVKHLD TASQDKESKI
370 380 390 400 410 420
LIFASTKRTC DEITSYLRQD GWPALAIHGD KDQRERDWVL NEFRTGNSPI MVATDVAARG
430 440 450 460 470 480
IDVKGINFVV NYDMPGNIED YVHRIGRTGR AGATGTAISF FTEDNKSLGA SLISIMREAK
490 500 510 520 530 540
QNIPEELMKY DRRPRGPHPR YGGGYGRGGR GYGGGRGGYG GRGGGRGGRG GFNRSRDGGW
GNRR